Featured tests
NEO PanTracer Pro
PanTracer Pro combines a tissue-based CGP test with IHC and ancillary testing by tumor type. It covers 517 genes by DNA for SNVs and InDels, 59 genes by DNA for CNVs, and 55 genes by RNA for known and novel fusions and splice variants, and includes TMB and MSI. It also provides HRD status for ovarian patients and disease-specific IHCs and ancillary testing. LBx reflex/concurrent workflow is available.
NEO PanTracer Tissue (formerly Neo Comprehensive - Solid Tumor)
Formerly Neo Comprehensive - Solid Tumor. NGS comprehensive genomic profile targeting 517 genes in DNA and RNA for SNVs, InDels, CNVs, RNA fusions/splice variants with MSI and TMB for pan-solid tumors.
NEO PanTracer LBx
Liquid biopsy NGS comprehensive genomic profile targeting 514 genes for SNVs, InDels, CNVs, and fusions with MSI-High and bTMB for advanced stage pan-solid tumors.